Assessment of Oxidative Stress Markers in Hypothermic Preservation of Transplanted Kidneys

Tejchman, Karol; Sierocka, Anita; Kotfis, Katarzyna; Kotowski, Maciej; Dołęgowska, Barbara; Ostrowski, Marek; Sieńko, Jerzy

doi:10.3390/antiox10081263

“…However, during the reperfusion phase, intracellular reactive oxygen species (ROS) are generated, and the intracellular redox balance is disrupted, resulting in more severe renal injury than during the ischemic period. Therefore, reperfusion injury is dominated by excessive oxidative stress [ 2 , 3 ]. Some researchers have studied the activities of enzymes and levels of nonenzymatic components involved in the antioxidant defense.…”

Section: Introductionmentioning

confidence: 99%

Ginsenoside Rg1 Ameliorates Acute Renal Ischemia/Reperfusion Injury via Upregulating AMPKα1 Expression

Zhou

¹

,

He

²

,

Zhao

³

et al. 2022

Oxidative Medicine and Cellular Longevity

View full text Add to dashboard Cite

Acute renal ischemia/reperfusion (I/R) injury often occurs during kidney transplantation and other kidney surgeries, and the molecular mechanism involves oxidative stress. We hypothesized that ginsenoside Rg1 (Rg1), a saponin derived from ginseng, would protect the renal tissue against acute renal I/R injury by upregulating 5 ′ adenosine monophosphate-activated protein kinase α1 (AMPKα1) expression and inhibiting oxidative stress. The models of acute anoxia/reoxygenation (A/R) damage in normal rat kidney epithelial cell lines (NRK-52E) and acute renal I/R injury in mice were constructed. The results revealed that pretreatment with 25 μM Rg1 significantly increased NRK-52E viability, decreased lactate dehydrogenase (LDH) activity and apoptosis, suppressed reactive oxygen species generation and oxidative stress, stabilized mitochondrial membrane potential and reduced mitochondria permeability transition pore openness, decreased adenosine monophosphate/adenosine triphosphate ratio, and upregulated the expression of AMPKα1, cytochrome b-c1 complex subunit 2, NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 8, and B-cell lymphoma 2, while downregulating BCL2-associated X protein expression. The effects of Rg1 pretreatment were similar to those of pAD/Flag-AMPKα1. After acute renal I/R injury, serum creatinine, blood urea nitrogen, LDH activity, and oxidative stress in renal tissue significantly increased. Rg1 pretreatment upregulated AMPKα1 expression, which protects against acute renal I/R injury by maintaining renal function homeostasis, inhibiting oxidative stress, and reducing apoptosis. Compound C, a specific inhibitor of AMPK, reversed the effects of Rg1. In summary, Rg1 pretreatment upregulated AMPKα1 expression, inhibited oxidative stress, maintained mitochondrial function, improved energy metabolism, reduced apoptosis, and ultimately protected renal tissue against acute renal I/R injury.

show abstract

“…Moreover, it would be hard to conclude that the blood count alterations observed in the repeated measurements after KTx were unrelated to factors other than oxidative stress or acidosis. As the authors suggest, many other factors may modify blood count, including operative stress, bleeding, immunosuppression, and microaggregation [117].…”

Section: New Solutions In Perfusion Controlmentioning

confidence: 99%

A Review of Current and Emerging Trends in Donor Graft-Quality Assessment Techniques

Warmuzińska

¹

,

Łuczykowski

²

,

Bojko

³

2022

JCM

View full text Add to dashboard Cite

The number of patients placed on kidney transplant waiting lists is rapidly increasing, resulting in a growing gap between organ demand and the availability of kidneys for transplantation. This organ shortage has forced medical professionals to utilize marginal kidneys from expanded criteria donors (ECD) to broaden the donor pool and shorten wait times for patients with end-stage renal disease. However, recipients of ECD kidney grafts tend to have worse outcomes compared to those receiving organs from standard criteria donors (SCD), specifically increased risks of delayed graft function (DGF) and primary nonfunction incidence. Thus, representative methods for graft-quality assessment are strongly needed, especially for ECDs. Currently, graft-quality evaluation is limited to interpreting the donor’s recent laboratory tests, clinical risk scores, the visual evaluation of the organ, and, in some cases, a biopsy and perfusion parameters. The last few years have seen the emergence of many new technologies designed to examine organ function, including new imaging techniques, transcriptomics, genomics, proteomics, metabolomics, lipidomics, and new solutions in organ perfusion, which has enabled a deeper understanding of the complex mechanisms associated with ischemia-reperfusion injury (IRI), inflammatory process, and graft rejection. This review summarizes and assesses the strengths and weaknesses of current conventional diagnostic methods and a wide range of new potential strategies (from the last five years) with respect to donor graft-quality assessment, the identification of IRI, perfusion control, and the prediction of DGF.

show abstract

“…Our Special Issue presents innovative research [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 ] and review [ 13 , 14 , 15 ] papers addressing many of these questions related to the fundamental OS involvement in the onset and progression of several acute and chronic diseases, and about the correlated biomarkers and potential therapies. Precisely, the 12 research articles [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 ] included in this Special Issue are focused on evidencing the OS role in diagnostics, signatures of the disease course, molecules involved, OS potential treatments and effects, and short- and long-term consequences.…”

mentioning

confidence: 99%

“…Our Special Issue presents innovative research [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 ] and review [ 13 , 14 , 15 ] papers addressing many of these questions related to the fundamental OS involvement in the onset and progression of several acute and chronic diseases, and about the correlated biomarkers and potential therapies. Precisely, the 12 research articles [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 ] included in this Special Issue are focused on evidencing the OS role in diagnostics, signatures of the disease course, molecules involved, OS potential treatments and effects, and short- and long-term consequences. Precisely, Chen et al [ 1 ], by performing a nano-electrospray ionization–mass spectrometry (nanoESI-MS)-based lipidomic profiling study on lipid accumulation and oxidation in kidney cells in the chronic kidney disease (CKD) model, confirmed the key role of OS and lipid dysregulation in renal lipid droplet (LD) alteration at the molecular level.…”

mentioning

confidence: 99%